BCDA (BCDA) Stock Price & Analysis
BCDA (BCDA) fell 0.92% to USD 1.08 as of September 8, 2026 at 06:54 UTC, according to Nexqual real-time market data.
BCDA last closed at USD 1.08; the session ranged USD 1.06–1.08 on volume of 58,196 shares. Market capitalization is —, with a 52-week range of USD 0.75–2.29 (NCM). Source: Nexqual, September 8, 2026 at 06:54 UTC.
Key Statistics (as of September 8, 2026 at 06:54 UTC)
| Price | USD 1.08 |
|---|---|
| Change | ▼ 0.92% (down) |
| Previous Close | USD 1.08 |
| Open | USD 1.08 |
| Day Range | USD 1.06 – 1.08 |
| 52-Week Range | USD 0.75 – 2.29 |
| Volume | 58,196 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (BCDA)
Nexqual's technical model rates BCDA "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 06:54 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 56.04 (neutral) |
| vs SMA50 | Above (USD 0.98) |
| MACD | 0.05 (positive) |
Earnings (BCDA)
| EPS Estimate | USD -0.15 |
|---|---|
| Revenue Estimate | $0 |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD -0.13 vs est -0.19 ▲ beat |
| 2026-03-31 | USD -0.21 vs est -0.17 ▼ miss |
| 2025-12-31 | USD -0.06 vs est -0.2 ▲ beat |
| 2025-09-30 | USD -0.24 vs est -0.25 ▲ beat |
Source: Nexqual, September 8, 2026 at 06:54 UTC.
Financials & Fundamentals (BCDA)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| ROE | -1803.19% |
| Debt / Equity | 10.85 |
| Current Ratio | 2.09 |
| Total Cash | $4.12M |
| Total Debt | $293,000 |
| Free Cash Flow | $-5.66M |
Source: Nexqual, September 8, 2026 at 06:54 UTC.
Ownership (BCDA)
| Insider Ownership | +23.19% |
|---|---|
| Institutional Ownership | +9.50% |
| Shares Outstanding | 15.14M |
| Float | 12.27M |
| Short % of Float | +7.76% |
Source: Nexqual, September 8, 2026 at 06:54 UTC.
From BCDA's Latest SEC 10-K Filing (filed 2026-03-24)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ADIL | Adial Pharmaceuticals, Inc | USD 7.12 | ▲ 12.66% |
| ENSC | Ensysce Biosciences, Inc. | USD 0.46 | ▲ 2.93% |
| NMAD | Nomad Power Solutions, Inc. | USD 4.03 | ▲ 8.63% |
| PHIO | Phio Pharmaceuticals Corp. | USD 1.08 | ▼ 4.42% |
| ARDS | Aridis Pharmaceuticals Inc. | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:54 UTC. This page is informational and not investment advice.